Endovascular correction of cerebrovenous anomalies in multiple sclerosis: A retrospective review of an uncontrolled case series

Vascular Medicine (United Kingdom)

Volumn 17, Issue 3, 2012, Pages 131-137

  Dake, Michael D ^a   Dantzker, Nicholas ^a   Bennett, William L ^a   Cooke, John P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

inflammation; internal jugular vein; stent; superior vena cava syndrome

Indexed keywords

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CASE STUDY; CHRONIC CEREBROSPINAL VENOUS INSUFFICIENCY; CLINICAL ARTICLE; CLINICAL OBSERVATION; COGNITION; DISEASE COURSE; FEMALE; HEART SURGERY; HEMODYNAMICS; HUMAN; MALE; MORTALITY; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PRESSURE GRADIENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STENT; STENT THROMBOSIS; VEIN BLOOD FLOW; VENOUS PRESSURE;

ADULT; AGED; ANGIOPLASTY; CEREBROVASCULAR DISORDERS; CONSTRICTION, PATHOLOGIC; FEMALE; HUMANS; JUGULAR VEINS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RETROSPECTIVE STUDIES; STENTS; SUPERIOR VENA CAVA SYNDROME; VENOUS INSUFFICIENCY; YOUNG ADULT;

EID: 84861795802     PISSN: 1358863X     EISSN: 14770377     Source Type: Journal    
DOI: 10.1177/1358863X12440125     Document Type: Article

References (28)

1. Zamboni P, Menegatti E, Galeotti R, et al. The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis. J Neurol Sci. 2009 ; 282: 21-27
2. Zamboni P, Galeotti R, Menegatti E, et al. Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2009 ; 80: 392-399
3. Kee ST, Kinoshita L, Razavi MK, Nyman UR, Semba CP, Dake MD. Superior vena cava syndrome: treatment with catheter-directed thrombolysis and endovascular stent placement. Radiology. 1998 ; 206: 187-193
4. Kurtzke JF. Historical and clinical perspectives of the expanded disability status scale. Neuroepidemiology. 2008 ; 31: 1-9 (Pubitemid 351957392)
5. Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis. Washington, DC: Paralyzed Veterans of America ; 1998 :
6. Doepp F, Paul F, Valdueza JM, et al. No cerebral venous congestion in patients with multiple sclerosis. Ann Neurol. 2010 ; 68: 173-183
7. Tsivgoulis G, Mantatzis M, Bogiatzi C, et al. Extracranial venous hemodynamics in multiple sclerosis: a case-control study. Neurology. 2011 ; 77: 1241-1245
8. Sundstrom P, Wahlin A, Ambarki K, et al. Venous and cerebrospinal fluid flow in multiple sclerosis: a case-controlled study. Ann Neurol. 2010 ; 68: 255-259
9. Zivadinov R, Lopez-Soriano A, Weinstock-Guttman B, et al. Use of MR venography for characterization of the extracranial venous system in patients with multiple sclerosis and healthy control subjects. Radiology. 2011 ; 258: 562-570
10. Ge Y, Law M, Johnson G, et al. Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. AJNR Am J Neuroradiol. 2005 ; 26: 1539-1547 (Pubitemid 43733458)
11. Inglese M, Adhya S, Johnson G, et al. Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis. J Cereb Blood Flow Metab. 2008 ; 28: 164-171
12. Cooke JP. Flow, NO, and atherogenesis. Proc Natl Acad Sci U S A. 2003 ; 100: 768-770 (Pubitemid 36183903)
13. Bergan J. Molecular mechanisms in chronic venous insufficiency. Ann Vasc Surg. 2007 ; 21: 260-266 (Pubitemid 46678673)
14. Zamboni P. The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. J R Soc Med. 2006 ; 99: 589-593 (Pubitemid 44876813)
15. Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging. 2001 ; 18: 685-716 (Pubitemid 32948277)
16. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000 ; 87: 840-844
17. Tsao PS, Buitrago R, Chan JR, Cooke JP. Fluid flow inhibits endothelial adhesiveness: Nitric oxide and transcriptional regulation of VCAM-1. Circulation. 1996 ; 94: 1682-1689 (Pubitemid 26320275)
18. Tsao PS, Wang B, Buitrago R, Shyy JY, Cooke JP. Nitric oxide regulates monocyte chemotactic protein-1. Circulation. 1997 ; 96: 934-940 (Pubitemid 27329631)
19. Kurz X, Kahn SR, Abenhaim L, et al. Chronic venous disorders of the leg: epidemiology, outcomes, diagnosis and management. Summary of an evidence-based report of the VEINES task force. Venous insufficiency epidemiologic and economic studies. Int Angiol. 1999 ; 18: 83-102
20. Fog T. The topography of plaques in multiple sclerosis with special reference to cerebral plaques. Acta Neurol Scand. 1965 ; 15: 1-161
21. Putnam TJ. Lesions of 'encephalomyelitis' and multiple sclerosis. Venous thrombosis as the primary alteration. JAMA. 1937 1477 ; 108 :
22. Haacke EM, Makki M, Ge Y, et al. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging. 2009 ; 29: 537-544
23. Rebeles F, Fink J, Anzai Y, Maravilla KR. Blood-brain barrier imaging and therapeutic potentials. Top Magn Reson Imaging. 2006 ; 17: 107-116 (Pubitemid 46050573)
24. Birch MK, Barbosa S, Blumhardt LD, O'Brien C, Harding SP. Retinal venous sheathing and the blood-retinal barrier in multiple sclerosis. Arch Ophthalmol. 1996 ; 114: 34-39 (Pubitemid 26026191)
25. Stich O, Janowitz D, Rauer S. Spontaneous intracerebral hemorrhage in a patient with multiple sclerosis and tumefactive demyelinating lesion. Mult Scler. 2009 ; 15: 517-519
26. Zamboni P, Galeotti R, Menegatti E, et al. A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. J Vasc Surg. 2009 ; 50: 1348-1358
27. Han MH, Hwang SI, Roy DB, et al. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature. 2008 ; 451: 1076-1081 (Pubitemid 351317445)
28. Ann Neurol. 2010 ; 67: A13-15